Pharmacology
All Targets
7-TM Receptors
Ion Channels
Nuclear Receptors
Enzyme-Linked Receptors
Transporters
Enzymes
Other Pharmacology
Cellular Processes
Angiogenesis
Apoptosis
Cell Cycle
Cell Metabolism
Cytoskeleton & Motor Proteins
ECM & Adhesion Molecules
Epigenetics 
Signal Transduction
Stem Cells
Signaling Pathways
Product Type
All Products
New Products
Small Molecules
Peptides
Controlled Substances
Toxins
Caged Compounds
Fluorescent Probes
Screening Libraries
Ligand Sets
Other Product Types
Research Area
Cancer
Cardiovascular System
Endocrinology
Immunology
Neuroscience
Pain & Inflammation
Respiratory System
Signal Transduction
Stem Cells
Signaling Pathways
Product Type
All Products
New Products
Small Molecules
Peptides
Controlled Substances
Toxins
Caged Compounds
Fluorescent Probes
Screening Libraries
Ligand Sets
Other Product Types
Research Area
Cancer
Cardiovascular System
Endocrinology
Immunology
Neuroscience
Pain & Inflammation
Respiratory System
Voltage-gated Calcium Channels (CaV)
More Information »Voltage-gated calcium channels (CaV) are present in the membrane of most excitable cells and mediate calcium influx in response to depolarization. They regulate intracellular processes such as contraction, secretion, neurotransmission and gene expression.
Voltage-gated Calcium Channel (CaV) Products
Activators |
|
Cat.No. |
Product Name / Activity |
| 1544 | (±)-Bay K 8644 |
| Ca2+-channel activator (L-type) | |
| 1546 | (S)-(-)-Bay K 8644 |
| Ca2+-channel activator (L-type) | |
| 1403 | FPL 64176 |
| Potent activator of Ca2+ channels (L-type) | |
| 2851 | Nefiracetam |
| Cognitive enhancer; activates L/N-type Ca2+ channels | |
Blockers |
|
Cat.No. |
Product Name / Activity |
| 2799 | ω-Agatoxin IVA |
| Ca2+ channel blocker (P-type) | |
| 2802 | ω-Agatoxin TK |
| Ca2+ channel blocker (P/Q-type) | |
| 2571 | Amlodipine besylate |
| Ca2+ channel blocker (L-type) | |
| 1545 | (R)-(+)-Bay K 8644 |
| Ca2+-channel blocker (L-type) | |
| 3934 | Benidipine hydrochloride |
| Calcium channel blocker | |
| 4117 | Bepridil hydrochloride |
| Non-selective calcium channel blocker | |
| 2629 | Cilnidipine |
| Ca2+ channel blocker (dual L/N-type) | |
| 1085 | ω-Conotoxin GVIA |
| Ca2+ channel blocker (N-type) | |
| 1084 | ω-Conotoxin MVIIC |
| Ca2+ channel blocker (N, P and Q-type) | |
| 0685 | Diltiazem hydrochloride |
| Ca2+ channel blocker (L-type) | |
| 3733 | Efonidipine hydrochloride monoethanolate |
| Ca2+ channel blocker (L- and T-type) | |
| 2960 | Felodipine |
| Ca2+ channel blocker (L-type) | |
| 0522 | Flunarizine dihydrochloride |
| Dual Na+/Ca2+ channel (T-type) blocker | |
| 2004 | Isradipine |
| Ca2+ channel blocker (L-type) | |
| 3086 | L-651,582 |
| Ca2+ channel blocker | |
| 2959 | Lercanidipine hydrochloride |
| Ca2+ channel blocker (L-type) | |
| 0840 | Loperamide hydrochloride |
| Ca2+ channel blocker (HVA) (L/N-type) | |
| 2198 | Mibefradil dihydrochloride |
| Ca2+ channel blocker (T-type) | |
| 4507 | ML 218 hydrochloride |
| Ca2+ channel blocker (T-type) | |
| 1075 | Nifedipine |
| Ca2+ channel blocker (L-type) | |
| 1124 | (R)-(-)-Niguldipine hydrochloride |
| Ca2+ channel blocker (L-type). Less active enantiomer of Cat. No. 1123 | |
| 1123 | (S)-(+)-Niguldipine hydrochloride |
| Ca2+ channel blocker (L-type) | |
| 0600 | Nimodipine |
| Ca2+ channel blocker (L-type) | |
| 0601 | Nitrendipine |
| Ca2+ channel blocker (L-type) | |
| 2268 | NNC 55-0396 dihydrochloride |
| Highly selective Ca2+ channel blocker (T-type) | |
| 3552 | PD 173212 |
| Potent N-type Ca2+ channel blocker | |
| 4665 |
ProTx I
|
| CaV3.1 channel blocker; also inhibits NaV1.8 and KV2.1 | |
| 1439 | Ruthenium Red |
| Non-selective Ca2+ channel blocker (N- and P-type) | |
| 2945 | SNX 482 |
| Potent and selective CaV2.3 blocker (R-type) | |
| 1806 | SR 33805 oxalate |
| Ca2+ channel blocker; binds allosterically to distinct site on L-type channels | |
| 0654 | Verapamil hydrochloride |
| Ca2+ channel blocker (L-type) | |
Other |
|
Cat.No. |
Product Name / Activity |
| 4055 | L-Ascorbic acid |
| Selective inhibitor of Cav3.2 channels | |
| 0806 | Gabapentin |
| Selectively binds the α2δ subunit of CaV channels. Anticonvulsant | |
| 3775 | Pregabalin |
| Anticonvulsant. Selectively binds the α2δ subunit of voltage-sensitive calcium channels | |
Related Categories
Quick Order
Find multiple products by catalog number
Pain Research Guide
Reserve your free copy
Highlights over 280 products for Pain research. Reserve copy
Calcium Imbalance and Neuroprotective Targets
Written by E. Besancon et al
'Calcium Imbalance and Neuro-protective Targets in Cerebral Ischemia & Brain Injury' highlights the key targets involved in stroke, trauma and neurodegeneration.
Antidepressants - Current and Future Targets
Written by P. Skolnich et al
'Antidepressants - Current and Future Targets' provides an overview of the current and future targets for the treatment of major depressive disorder.
Twitter Updates
Follow @Tocris on Twitter
Tocris is now actively tweeting. For regular updates on news, events and special offers, follow @Tocris on Twitter.